Sort
23,748 grants matching “melanoma”
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$513,119Lishan Su · University Of Maryland Baltimore · R01 · FY2023 · AI
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$513,111David Reardon · Duke University · P50 · FY2012 · NS
The Consistency of Behavioral Plasticity Across Different Selective Contexts.
$512,998William E Wagner · University Of Nebraska-Lincoln · · FY2012 · BIO
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
$512,889Sheila H Ridner · Vanderbilt University · R01 · FY2012 · CA
Solar Exposure and Melanoma Survival
$512,756University Of New Mexico · R01 · FY2005 · CA
Community Outreach and Engagement
$512,726Alyce Sophia Adams · Stanford University · P30 · FY2022 · CA
Community Outreach and Engagement
$512,726Alyce Sophia Adams · Stanford University · P30 · FY2023 · CA
Community Outreach and Engagement
$512,726Alyce Sophia Adams · Stanford University · P30 · FY2024 · CA
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
$512,601Michael Croft · La Jolla Institute For Immunology · R01 · FY2022 · CA
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
$512,601Michael Croft · La Jolla Institute For Immunology · R01 · FY2023 · CA
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms
$512,489Peggy Reynolds · University Of California, San Francisco · R01 · FY2019 · CA
SPORE in Skin Cancer
$512,285Thomas S. Kupper · Brigham And Women'S Hospital · P50 · FY2007 · CA
DISPLAY METHODS FOR SURVEYING MUTATIONS
$512,242Yale University · R33 · FY2003 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$512,222Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA
Biochemistry Core
$512,140Duck-Yeon Lee · National Heart, Lung, And Blood Institute · ZIC · FY2021 · HL
IL-1 HOMOLOGUES PROMOTE THE ACUTE INFLAMMATORY RESPONSE TO MELANOMA
$512,103Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Functional analysis of a novelintegrin-dependent metastasis pathway in melanoma
$511,820Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2025 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$511,800Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2024 · CA
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
$511,750Sara Lindstroem · University Of Washington · R01 · FY2022 · CA
NIA Confocal Imaging Facility
$511,703Fred Indig · National Institute On Aging · ZIC · FY2017 · AG
Therapeutic strategies for treatment of giant congenital melanocytic nevi
$511,688David E Fisher · Massachusetts General Hospital · R01 · FY2023 · AR
Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis
$511,659Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
$511,480Noriyuki Kasahara · University Of California, San Francisco · R01 · FY2019 · CA
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$511,429Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2025 · CA
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
$511,345Glenn T. Merlino · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA